Literature DB >> 19121928

Understanding post 9/11 drug control policy and politics in Central Asia.

Alisher Latypov1.   

Abstract

This paper exposes contemporary drug policy challenges in Central Asia by focusing on a single point in the history of drug control, in a single region of the global war against drugs and terrorism, and on one agency whose mission is to help make the world safer from crime, drugs and terrorism. By looking closely at the post 9/11 security-oriented donor priorities, I conclude that, in Central Asia, the rhetoric of the taking a more 'balanced approach' to drug policy is bankrupt. When enacted by the national law enforcement agencies in the Central Asian republics, the 'Drug Free' aspirational goal is driving the HIV epidemic among IDUs. The face-saving 'containment' thesis does not reflect the drug situation in this region but rather the failure to adopt an evidence-based approach. The harm reduction agenda continues to face many challenges including resistance to substitution treatment, the harm from drug treatment, from poorly designed drug prevention programmes and from repressive counter-narcotics policies and practices.

Entities:  

Mesh:

Year:  2009        PMID: 19121928     DOI: 10.1016/j.drugpo.2008.11.002

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  2 in total

1.  'It's risky to walk in the city with syringes': understanding access to HIV/AIDS services for injecting drug users in the former Soviet Union countries of Ukraine and Kyrgyzstan.

Authors:  Neil Spicer; Daryna Bogdan; Ruairi Brugha; Andrew Harmer; Gulgun Murzalieva; Tetiana Semigina
Journal:  Global Health       Date:  2011-07-13       Impact factor: 4.185

2.  Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach.

Authors:  Umedjon Ibragimov; Hannah L Cooper; Regine Haardörfer; Kristin L Dunkle; William A Zule; Frank Y Wong
Journal:  Harm Reduct J       Date:  2017-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.